CUV 7.30% $19.93 clinuvel pharmaceuticals limited

company presentation

  1. 6,269 Posts.
    lightbulb Created with Sketch. 126
    I looked over their company presentation they have achieved and it is inevitable as mentioned in the report that a Big Phar Company will seek to partner with and already they have been approached by companies regarding the Melanotan. They are seeking FDA approval next month, which will be another boost. I dont see them seeking extra funds as they mentioned they will commercialise their developement through a partnership. The company has NO Borrowings and Debt and shares on issue is small considering other Biotec companies. And they have a world patent rights which means no competion. Looks good to me. This stock is bound to reach over the $1.00 mark again and I feel confident that will go even further in share price. Anothe good Aussie invention.

watchlist Created with Sketch. Add CUV (ASX) to my watchlist
(20min delay)
Mkt cap ! $1.062B
Open High Low Value Volume
$20.57 $20.79 $19.92 $13.48M 667.4K

Buyers (Bids)

No. Vol. Price($)
1 158 $19.93

Sellers (Offers)

Price($) Vol. No.
$19.97 1500 1
View Market Depth
Last trade - 16.10pm 27/02/2020 (20 minute delay) ?
-1.570 ( 7.27 %)
Open High Low Volume
$20.13 $20.68 $19.92 32123
Last updated 15.59pm 27/02/2020 (live) ?
CUV (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.